RASGRP4 and diffuse large B-cell lymphoma: We report that reduction of RasGRP4 expression in DLBCL cells led to significant inhibition of cell proliferation in vitro and suppressed tumor growth in a nude mouse model in vivo by modulating the MAPK-associated signaling pathway.